NO327638B1 - Krystallpolymorfisme av aminoetylfenoksyeddiksyre derivater - Google Patents
Krystallpolymorfisme av aminoetylfenoksyeddiksyre derivater Download PDFInfo
- Publication number
- NO327638B1 NO327638B1 NO20013537A NO20013537A NO327638B1 NO 327638 B1 NO327638 B1 NO 327638B1 NO 20013537 A NO20013537 A NO 20013537A NO 20013537 A NO20013537 A NO 20013537A NO 327638 B1 NO327638 B1 NO 327638B1
- Authority
- NO
- Norway
- Prior art keywords
- ethyl
- phenoxy
- hydroxy
- amino
- hydroxyphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1363999 | 1999-01-21 | ||
PCT/JP2000/000168 WO2000043350A1 (fr) | 1999-01-21 | 2000-01-17 | Polymorphisme cristallin de derive d'acide aminoethylphenoxyacetique |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20013537D0 NO20013537D0 (no) | 2001-07-17 |
NO20013537L NO20013537L (no) | 2001-09-18 |
NO327638B1 true NO327638B1 (no) | 2009-09-07 |
Family
ID=11838822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013537A NO327638B1 (no) | 1999-01-21 | 2001-07-17 | Krystallpolymorfisme av aminoetylfenoksyeddiksyre derivater |
Country Status (23)
Country | Link |
---|---|
US (1) | US6376707B1 (cs) |
EP (1) | EP1146035B1 (cs) |
JP (1) | JP4005771B2 (cs) |
KR (1) | KR100604712B1 (cs) |
CN (1) | CN1216855C (cs) |
AR (1) | AR022319A1 (cs) |
AT (1) | ATE309978T1 (cs) |
AU (1) | AU778091B2 (cs) |
CA (1) | CA2359061C (cs) |
CO (1) | CO5160240A1 (cs) |
CZ (1) | CZ302572B6 (cs) |
DE (1) | DE60024053T2 (cs) |
DK (1) | DK1146035T3 (cs) |
ES (1) | ES2251956T3 (cs) |
IL (1) | IL144253A (cs) |
MY (1) | MY119093A (cs) |
NO (1) | NO327638B1 (cs) |
NZ (1) | NZ512965A (cs) |
PE (1) | PE20001398A1 (cs) |
RU (1) | RU2237656C2 (cs) |
TW (1) | TWI223647B (cs) |
WO (1) | WO2000043350A1 (cs) |
ZA (1) | ZA200105830B (cs) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998013333A1 (fr) * | 1996-09-26 | 1998-04-02 | Kissei Pharmaceutical Co., Ltd. | Derives de 2-amino-1-(4-hydroxy-2-methylphenyl)propanol |
ID24062A (id) * | 1997-07-25 | 2000-07-06 | Kissei Pharmaceutical | Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing |
EP1072583B1 (en) * | 1998-04-14 | 2004-09-01 | Kissei Pharmaceutical Co., Ltd. | 2-methylpropionic acid derivatives and medicinal compositions containing the same |
-
2000
- 2000-01-17 DE DE60024053T patent/DE60024053T2/de not_active Expired - Lifetime
- 2000-01-17 US US09/889,857 patent/US6376707B1/en not_active Expired - Fee Related
- 2000-01-17 CN CN008030251A patent/CN1216855C/zh not_active Expired - Fee Related
- 2000-01-17 CZ CZ20012621A patent/CZ302572B6/cs not_active IP Right Cessation
- 2000-01-17 IL IL14425300A patent/IL144253A/en not_active IP Right Cessation
- 2000-01-17 ES ES00900407T patent/ES2251956T3/es not_active Expired - Lifetime
- 2000-01-17 JP JP2000594768A patent/JP4005771B2/ja not_active Expired - Fee Related
- 2000-01-17 NZ NZ512965A patent/NZ512965A/xx not_active IP Right Cessation
- 2000-01-17 DK DK00900407T patent/DK1146035T3/da active
- 2000-01-17 AU AU20047/00A patent/AU778091B2/en not_active Ceased
- 2000-01-17 AT AT00900407T patent/ATE309978T1/de active
- 2000-01-17 CA CA002359061A patent/CA2359061C/en not_active Expired - Fee Related
- 2000-01-17 EP EP00900407A patent/EP1146035B1/en not_active Expired - Lifetime
- 2000-01-17 RU RU2001120343A patent/RU2237656C2/ru not_active IP Right Cessation
- 2000-01-17 WO PCT/JP2000/000168 patent/WO2000043350A1/ja active IP Right Grant
- 2000-01-17 KR KR1020017009176A patent/KR100604712B1/ko not_active Expired - Fee Related
- 2000-01-17 PE PE2000000030A patent/PE20001398A1/es not_active Application Discontinuation
- 2000-01-18 MY MYPI20000146A patent/MY119093A/en unknown
- 2000-01-20 AR ARP000100247A patent/AR022319A1/es active IP Right Grant
- 2000-01-20 TW TW089100860A patent/TWI223647B/zh not_active IP Right Cessation
- 2000-01-20 CO CO00002898A patent/CO5160240A1/es unknown
-
2001
- 2001-07-16 ZA ZA200105830A patent/ZA200105830B/xx unknown
- 2001-07-17 NO NO20013537A patent/NO327638B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2237656C2 (ru) | 2004-10-10 |
ZA200105830B (en) | 2002-09-25 |
TWI223647B (en) | 2004-11-11 |
IL144253A (en) | 2004-08-31 |
NO20013537D0 (no) | 2001-07-17 |
DE60024053T2 (de) | 2006-07-20 |
PE20001398A1 (es) | 2000-12-22 |
AR022319A1 (es) | 2002-09-04 |
EP1146035B1 (en) | 2005-11-16 |
MY119093A (en) | 2005-03-31 |
ATE309978T1 (de) | 2005-12-15 |
CZ302572B6 (cs) | 2011-07-20 |
CO5160240A1 (es) | 2002-05-30 |
EP1146035A9 (en) | 2001-12-05 |
CN1337937A (zh) | 2002-02-27 |
JP4005771B2 (ja) | 2007-11-14 |
IL144253A0 (en) | 2002-05-23 |
ES2251956T3 (es) | 2006-05-16 |
CN1216855C (zh) | 2005-08-31 |
EP1146035A1 (en) | 2001-10-17 |
AU2004700A (en) | 2000-08-07 |
NZ512965A (en) | 2002-11-26 |
WO2000043350A1 (fr) | 2000-07-27 |
CZ20012621A3 (cs) | 2002-02-13 |
AU778091B2 (en) | 2004-11-18 |
NO20013537L (no) | 2001-09-18 |
DE60024053D1 (de) | 2005-12-22 |
DK1146035T3 (da) | 2006-03-27 |
CA2359061A1 (en) | 2000-07-27 |
KR100604712B1 (ko) | 2006-07-28 |
US6376707B1 (en) | 2002-04-23 |
CA2359061C (en) | 2004-04-06 |
KR20010092790A (ko) | 2001-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2663663C2 (ru) | Соль омекамтива мекарбила и способ ее получения | |
EA005588B1 (ru) | Соли производных 3,3-дифенилпропиламинов | |
US7989494B2 (en) | Polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide | |
CN110015955A (zh) | 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体 | |
US8916559B2 (en) | Crystalline compound of 7-[(3R)-3-amino-1-oxo-4-(2, 4, 5-trifluorophenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluoromethyl)-1, 2, 4 -triazolo[4,3-A]pyrazin | |
TW202220962A (zh) | 選擇性NaV抑制劑的結晶形式及其製備方法 | |
EP1861389A1 (fr) | Sel besylate de la 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoleine, sa preparation et son utilisation en therapeutique | |
JP2019523273A (ja) | ベリノスタットの多形形態、およびその調製のためのプロセス | |
TW200900392A (en) | Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same | |
JPH09221479A (ja) | アミノベンゼンスルホン酸誘導体一水和物及びその製造方法 | |
NO327638B1 (no) | Krystallpolymorfisme av aminoetylfenoksyeddiksyre derivater | |
RU2006142768A (ru) | Способ получения бисульфата атазанавира | |
EP3398946A1 (en) | Salt of morpholine derivative and crystalline form thereof, as well as preparation method, pharmaceutical composition and use of the same | |
OA12665A (en) | New anhydrous crystalline forms of gabapentin. | |
KR100536750B1 (ko) | 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물 | |
US11434226B2 (en) | Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof | |
JP4005729B2 (ja) | アミノエチルフェノキシ酢酸誘導体二水和物の結晶多形 | |
CA1088099A (fr) | Procede de preparation de nouveaux alcoxy anilides et composes ainsi obtenus | |
JP4005731B2 (ja) | アミノエチルフェノキシ酢酸誘導体の結晶多形 | |
KR101653816B1 (ko) | 결정형 사포그릴레이트 옥살산염 일수화물 또는 이의 무수물 | |
US20110251286A1 (en) | Crystalline salts and/or co-crystals of O-desmethyltramadol | |
CN1109677C (zh) | 氨基苯磺酸衍生物的单水合物及其制备方法 | |
WO1997001563A1 (fr) | Cristaux de benzoates bicozamycine stables | |
HK1218544B (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
KR20100088992A (ko) | (r)-시부트라민 염 및 그의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |